Transcriptional Regulation of the Human Prostacyclin Receptor Gene Is Dependent on Sp1, PU.1 and Oct-1 in Megakaryocytes and Endothelial Cells

Journal of Molecular Biology

Volumn 386, Issue 3, 2009, Pages 579-597

  Turner, Elizebeth C ^a   Kinsella, B Therese ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

gene expression; Oct 1; prostacyclin receptor; PU.1; Sp1

Indexed keywords

CIS ACTING ELEMENT; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROSTACYCLIN RECEPTOR; TRANS ACTING FACTOR; TRANSCRIPTION FACTOR PU 1;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME BINDING; GENE EXPRESSION; GENETIC CONSERVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MEGAKARYOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; RECEPTOR GENE; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

EID: 59649092769     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.12.030     Document Type: Article

References (77)

1. Gryglewski R.J. Prostacyclin among prostanoids. Pharmacol. Rep. 60 (2008) 3-11
2. Narumiya S., Sugimoto Y., and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79 (1999) 1193-1226
3. 2. Science 296 (2002) 539-541
4. Flavahan N. Balancing prostanoid activity in the human vascular system. Trends Pharmacol. Sci. 28 (2007) 106-110
5. Bing R. Myocardial ischemia and infarction: growth of ideas. Cardiovasc. Res. 51 (2001) 13-20
6. Kahn N.N., Mueller H.S., and Sinha A.K. Impaired prostaglandin E1/I2 receptor activity of human blood platelets in acute ischemic heart disease. Circ. Res. 66 (1990) 932-940
7. Lefer A. Prostacyclin, high density lipoproteins, and myocardial ischemia. Circulation 81 (1990) 2013-2015
8. Fetalvero K.M., Martin K.A., and Hwa J. Cardioprotective prostacyclin signaling in vascular smooth muscle. Prostaglandins Other Lipid Mediators 82 (2007) 109-118
9. Kobayashi T., Tahara Y., Matsumoto M., Iguchi M., Sano H., Murayama T., et al. Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice. J. Clin. Invest. 114 (2004) 784-794
10. Neagoe P.E., Lemieux C., and Sirois M.G. Vascular endothelial growth factor (VEGF)-A165-induced prostacyclin synthesis requires the activation of VEGF receptor-1 and -2 heterodimer. J. Biol. Chem. 280 (2005) 9904-9912
11. Galie N., Manes A., and Branzi A. Prostanoids for pulmonary arterial hypertension. Am. J. Respir. Med. 2 (2003) 123-137
12. Pope J.E. The diagnosis and treatment of Raynaud's phenomenon: a practical approach. Drugs 67 (2007) 517-525
13. McAdam B.F., Catella-Lawson F., Mardini I.A., Kapoor S., Lawson J.A., and FitzGerald G.A. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc. Natl Acad. Sci. USA 96 (1999) 272-277
14. Murata T., Ushikubi F., Matsuoka T., Hirata M., Yamasaki A., Sugimoto Y., et al. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 388 (1997) 678-682
15. Sakai A., Yajima M., and Nishio S. Cytoprotective effect of TRK-100, a prostacyclin analogue, against chemical injuries in cultured human vascular endothelial cells. Life Sci. 47 (1990) 711-719
16. Fitzgerald G.A. Coxibs and cardiovascular disease. N. Engl. J. Med. 351 (2004) 1709-1711
17. Sugimoto Y., Narumiya S., and Ichikawa A. Distribution and function of prostanoid receptors: studies from knockout mice. Prog. Lipid Res. 39 (2000) 289-314
18. Bley K.R., Hunter J.C., Eglen R.M., and Smith J.A. The role of IP prostanoid receptors in inflammatory pain. Trends Pharmacol. Sci. 19 (1998) 141-147
19. Wise H., and Jones R.L. Focus on prostacyclin and its novel mimetics. Trends Pharmacol. Sci. 17 (1996) 17-21
20. van der Vuurst H., van Willigen G., van Spronsen A., Hendriks M., Donath J., and Akkerman J.W. Signal transduction through trimeric G proteins in megakaryoblastic cell lines. Arterioscler., Thromb., Vasc. Biol. 17 (1997) 1830-1836
21. Lawler O.A., Miggin S.M., and Kinsella B.T. Protein kinase A-mediated phosphorylation of serine 357 of the mouse prostacyclin receptor regulates its coupling to G(s)-, to G(i)-, and to G(q)-coupled effector signaling. J. Biol. Chem. 276 (2001) 33596-33607
22. Miggin S.M., and Kinsella B.T. Investigation of the mechanisms of G protein: effector coupling by the human and mouse prostacyclin receptors. Identification of critical species-dependent differences. J. Biol. Chem. 277 (2002) 27053-27064
23. Giovanazzi S., Accomazzo M.R., Letari O., Oliva D., and Nicosia S. Internalization and down-regulation of the prostacyclin receptor in human platelets. Biochem. J. 325 (1997) 71-77
24. Krane A., MacDermot J., and Keen M. Desensitization of adenylate cyclase responses following exposure to IP prostanoid receptor agonists. Homologous and heterologous desensitization exhibit the same time course. Biochem. Pharmacol. 47 (1994) 953-959
25. Leigh P.J., and MacDermot J. Desensitization of prostacyclin responsiveness in a neuronal hybrid cell line: selective loss of high affinity receptors. Br. J. Pharmacol. 85 (1985) 237-247
26. Smyth E.M., Austin S.C., Reilly M.P., and FitzGerald G.A. Internalization and sequestration of the human prostacyclin receptor. J. Biol. Chem. 275 (2000) 32037-32045
27. Smyth E.M., Li W.H., and FitzGerald G.A. Phosphorylation of the prostacyclin receptor during homologous desensitization. A critical role for protein kinase C. J. Biol. Chem. 273 (1998) 23258-23266
28. O'Keeffe M., Reid H., and Kinsella B. Agonist-dependent internalization and trafficking of the human prostacyclin receptor: a direct role for Rab5a GTPase. Biochim. Biophys. Acta (Mol. Cell Res.) 1783 (2008) 1914-1928
29. Miggin S.M., Lawler O.A., and Kinsella B.T. Investigation of a functional requirement for isoprenylation by the human prostacyclin receptor. Eur. J. Biochem. 269 (2002) 1714-1725
30. Egan K.M., Lawson J.A., Fries S., Koller B., Rader D.J., Smyth E.M., and Fitzgerald G.A. COX-2-derived prostacyclin confers atheroprotection on female mice. Science 306 (2004) 1954-1957
31. Sasaki Y., Takahashi T., Tanaka I., Nakamura K., Okuno Y., Nakagawa O., et al. Expression of prostacyclin receptor in human megakaryocytes. Blood 90 (1997) 1039-1046
32. Long M.W., Heffner C.H., Williams J.L., Peters C., and Prochownik E.V. Regulation of megakaryocyte phenotype in human erythroleukemia cells. J. Clin. Invest. 85 (1990) 1072-1084
33. Suggs J.E., Madden M.C., Friedman M., and Edgell C.J. Prostacyclin expression by a continuous human cell line derived from vascular endothelium. Blood 68 (1986) 825-829
34. Matsuoka T., and Narumiya S. Prostaglandin receptor signaling in disease. ScientificWorldJournal 7 (2007) 1329-1347
35. Ogawa Y., Tanaka I., Inoue M., Yoshitake Y., Isse N., Nakagawa O., et al. Structural organization and chromosomal assignment of the human prostacyclin receptor gene. Genomics 27 (1995) 142-148
36. Quandt K., Frech K., Karas H., Wingender E., and Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23 (1995) 4878-4884
37. Klemsz M.J., McKercher S.R., Celada A., Van Beveren C., and Maki R.A. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61 (1990) 113-124
38. Verrijzer C.P., and Van der Vliet P.C. POU domain transcription factors. Biochim. Biophys. Acta 1173 (1993) 1-21
39. Clerc R.G., Corcoran L.M., LeBowitz J.H., Baltimore D., and Sharp P.A. The B-cell-specific Oct-2 protein contains POU box- and homeo box-type domains. Genes Dev. 2 (1988) 1570-1581
40. He X., Treacy M.N., Simmons D.M., Ingraham H.A., Swanson L.W., and Rosenfeld M.G. Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature 340 (1989) 35-41
41. Arnosti D.N., Merino A., Reinberg D., and Schaffner W. Oct-2 facilitates functional preinitiation complex assembly and is continuously required at the promoter for multiple rounds of transcription. EMBO J. 12 (1993) 157-166
42. Zhao F.Q., Adachi K., and Oka T. Involvement of Oct-1 in transcriptional regulation of beta-casein gene expression in mouse mammary gland. Biochim. Biophys. Acta 1577 (2002) 27-37
43. Graves B.J., and Petersen J.M. Specificity within the ets family of transcription factors. Adv. Cancer Res. 75 (1998) 1-55
44. Oikawa T., and Yamada T. Molecular biology of the Ets family of transcription factors. Gene 303 (2003) 11-34
45. Bouïs D., Hospers G.A., Meijer C., Molema G., and Mulder N.H. Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research. Angiogenesis 4 (2001) 91-102
46. Struhl K. Yeast transcriptional regulatory mechanisms. Annu. Rev. Genet. 29 (1995) 651-674
47. Zhang Y., and Dufau M.L. Repression of the luteinizing hormone receptor gene promoter by cross talk among EAR3/COUP-TFI, Sp1/Sp3, and TFIIB. Mol. Cell. Biol. 23 (2003) 6958-6972
48. Li L., He S., Sun J.M., and Davie J.R. Gene regulation by Sp1 and Sp3. Biochem. Cell Biol. 82 (2004) 460-471
49. Block K.L., Shou Y., and Poncz M. An Ets/Sp1 interaction in the 5′-flanking region of the megakaryocyte-specific alpha IIb gene appears to stabilize Sp1 binding and is essential for expression of this TATA-less gene. Blood 88 (1996) 2071-2080
50. Gill G. Transcriptional initiation. Taking the initiative. Curr. Biol. 4 (1994) 374-376
51. Goodrich J.A., and Tjian R. TBP-TAF complexes: selectivity factors for eukaryotic transcription. Curr. Opin. Cell Biol. 6 (1994) 403-409
52. Holmes M.L., Bartle N., Eisbacher M., and Chong B.H. Cloning and analysis of the thrombopoietin-induced megakaryocyte-specific glycoprotein VI promoter and its regulation by GATA-1, Fli-1, and Sp1. J. Biol. Chem. 277 (2002) 48333-48341
53. Eisbacher M., Holmes M.L., Newton A., Hogg P.J., Khachigian L.M., Crossley M., and Chong B.H. Protein-protein interaction between Fli-1 and GATA-1 mediates synergistic expression of megakaryocyte-specific genes through cooperative DNA binding. Mol. Cell. Biol. 23 (2003) 3427-3441
54. Moreau-Gachelin F., Tavitian A., and Tambourin P. Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature 331 (1988) 277-280
55. DeKoter R.P., and Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 288 (2000) 1439-1441
56. Back J., Allman D., Chan S., and Kastner P. Visualizing PU.1 activity during hematopoiesis. Exp. Hematol. 33 (2005) 395-402
57. Back J., Dierich A., Bronn C., Kastner P., and Chan S. PU.1 determines the self-renewal capacity of erythroid progenitor cells. Blood 103 (2004) 3615-3623
58. Heydemann A., Juang G., Hennessy K., Parmacek M.S., and Simon M.C. The myeloid-cell-specific c-fes promoter is regulated by Sp1, PU.1, and a novel transcription factor. Mol. Cell. Biol. 16 (1996) 1676-1686
59. Zhang D.E., Hetherington C.J., Chen H.M., and Tenen D.G. The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol. Cell. Biol. 14 (1994) 373-381
60. Hagemeier C., Bannister A.J., Cook A., and Kouzarides T. The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc. Natl Acad. Sci. USA 90 (1993) 1580-1584
61. Kostyak J.C., and Naik U.P. Megakaryopoiesis: transcriptional insights into megakaryocyte maturation. Front. Biosci. 12 (2007) 2050-2062
62. Oikawa T., and Yamada T. Molecular biology of the Ets family of transcription factors. Genes Dev. 16 (2003) 11-34
63. Lord K.A., Abdollahi A., Hoffman-Liebermann B., and Liebermann D.A. Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation. Mol. Cell. Biol. 13 (1993) 841-851
64. Gegonne A., Bosselut R., Bailly R.A., and Ghysdael J. Synergistic activation of the HTLV1 LTR Ets-responsive region by transcription factors Ets1 and Sp1. EMBO J. 12 (1993) 1169-1178
65. Liu M., Leibowitz J.L., Clark D.A., Mendicino M., Ning Q., Ding J.W., et al. Gene transcription of fgl2 in endothelial cells is controlled by Ets-1 and Oct-1 and requires the presence of both Sp1 and Sp3. Eur. J. Biochem. 270 (2003) 2274-2286
66. Joo M., Park G.Y., Wright J.G., Blackwell T.S., Atchison M.L., and Christman J.W. Transcriptional regulation of the cyclooxygenase-2 gene in macrophages by PU.1. J. Biol. Chem. 279 (2004) 6658-6665
67. He X., Treacy M.N., Simmons D.M., Ingraham H.A., Swanson L.W., and Rosenfeld M.G. Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature 340 (1989) 35-42
68. Nishiyama C. Molecular mechanism of allergy-related gene regulation and hematopoietic cell development by transcription factors. Biosci., Biotechnol., Biochem. 70 (2006) 1-9
69. Chen H., Zhang P., Radomska H.S., Hetherington C.J., Zhang D.E., and Tenen D.G. Octamer binding factors and their coactivator can activate the murine PU.1 (spi-1) promoter. J. Biol. Chem. 271 (1996) 15743-15752
70. Kistler B., Pfisterer P., and Wirth T. Lymphoid- and myeloid-specific activity of the PU.1 promoter is determined by the combinatorial action of octamer and ets transcription factors. Oncogene 11 (1995) 1095-1106
71. Liu M., Leibowitz J.L., Clark D.A., Mendicino M., Ning Q., Ding J.W., et al. Gene transcription of fgl2 in endothelial cells is controlled by Ets-1 and Oct-1 and requires the presence of both Sp1 and Sp3. Eur. J. Biochem. 270 (2003) 2274-2286
72. Coyle A.T., and Kinsella B.T. Characterization of promoter 3 of the human thromboxane A receptor gene. A functional AP-1 and octamer motif are required for basal promoter activity. FEBS J. 272 (2005) 1036-1053
73. Shah P.C., Bertolino E., and Singh H. Using altered specificity Oct-1 and Oct-2 mutants to analyze the regulation of immunoglobulin gene transcription. EMBO J. 16 (1997) 7105-7117
74. Koch C.M., Andrews R.M., Flicek P., Dillon S.C., Karaöz U., Clelland G.K., et al. The landscape of histone modifications across 1% of the human genome in five human cell lines. Genome Res. 17 (2007) 691-707
75. Davis J., Davis D., Norman B., and Piatigorsky J. Gene expression of the mouse corneal crystallin Aldh3a1: activation by Pax6, Oct1, and p300. Invest. Ophthalmol. Visual Sci. 49 (2008) 1814-1826
76. Liu S., Luo H., Liu J., McNeilly A.S., and Cui S. Specificity protein 1 (Sp1) plays role in regulating LIM homeodomain transcription factor Lhx4 gene expression. Biochem. Biophys. Res. Commun. 366 (2008) 36-41
77. Unlu S., Kumar A., Waterman W.R., Tsukada J., Wang K.Z., Galson D.L., and Auron P.E. Phosphorylation of IRF8 in a pre-associated complex with Spi-1/PU.1 and non-phosphorylated Stat1 is critical for LPS induction of the IL1B gene. Mol. Immunol. 44 (2007) 3364-3379